| Cardiomyopathy |
1 |
1 |
| Arrhythmia |
0 |
0.9 |
| Exercise |
0 |
0.95 |
| Electrophysiology |
0 |
0.64 |
| Cardiovascular Imaging |
0 |
0.46 |
| Atrial Fibrillation |
0 |
0.35 |
| Ventricular Tachycardia |
0 |
0.22 |
| Syncope |
0 |
0.21 |
| Holter Monitor Testing |
0 |
0.16 |
| Cardiac MRI |
0 |
0.15 |
| Sudden Cardiac Death |
0 |
0.99 |
| Tachycardia |
0 |
0.15 |
| Abnormal ECG |
0 |
0.11 |
| Adolescent Medicine |
0 |
0.1 |
| Aneurysm |
0 |
0.1 |
| Cardiovascular Risk Management |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Echocardiography |
0 |
0.1 |
| Electrocardiogram (ECG) |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Implantable Cardioverter-Defibrillator |
0 |
0.1 |
| Magnetic Resonance Imaging |
0 |
0.1 |
| Sports Medicine |
0 |
0.1 |
| Anticoagulation Therapy |
0 |
0.05 |
| Athletics |
0 |
0.05 |
| Beta-Adrenergic Agonist |
0 |
0.05 |
| Cardiac Arrest |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| Defibrillator |
0 |
0.05 |
| Hypertrophic Cardiomyopathy |
0 |
0.98 |
| New York |
0 |
0.05 |